Global health sciences venture fund
North America, British Columbia, Canada, Vancouver
Description
The strength of the life science industry
Investor Profile
Global health sciences venture fund has made 9 investments, with 0 in the past 12 months and 22% as lead.
Stage Focus
- Series C (33%)
- Series A (22%)
- Series B (22%)
- Seed (11%)
- Series D (11%)
Country Focus
- United States (78%)
- France (11%)
- Spain (11%)
Industry Focus
- Biotechnology
- Therapeutics
- Life Science
- Health Care
- Pharmaceutical
- Medical
- Genetics
- Health Diagnostics
- Medical Device
- Information Technology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.